Editor - Mohammad Newaz | Chicago State University | 1332
ISSN: 2161-0479

Journal of Autacoids and Hormones
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mohammad Newaz

Mohammad Newaz
Mohammad Newaz
Associate Professor
College of Pharmacy
Chicago State University
Chicago State University


Mohammad Newaz MD PhD is an Associate Professor in the College of Pharmacy at Chicago state University Prior to joining Chicago State University in 2010 He was the Senior Scientist / Associate Professor and Head of Hypertension Unit in the Center for Cardiovascular Diseases at Texas Southern University, Houston. Dr. Newaz received his MD from University of Chittagong 1991 and PhD from the National University of Malaysia 1998. He has held faculty positions at the University of Science and Technology Chittagong Bangladesh National University of Malaysia and International Islamic University Malaysia before joining the Center for Cardiovascular Diseases in 2000. His laboratory focuses primarily on hypertension and vascular physiology using integrated investigative approach with special emphasis on understanding molecular events contributing to the pathogenesis of hypertension and its complications.

Research Interest

Present research focus involves understanding the role of Peroxisome Proliferator Activated Receptors (PPARs), a nuclear transcription factors, in the regulation of vascular function in hypertension and renal failure. This research involves an integrated approach encompassing system biology using biochemistry, molecular biology, physiology and pharmacologic approach to address the hypothesis related to vascular function. Using transgenic animals, we are addressing the interaction of NO/NOS system, reactive oxygen species and PPARs in different model of hypertension. We are also focusing on GPCR signalling in hypertension and their modulation by PPARs involving GRKs.



Global Speakers in the subject

Global Experts in the subject